Anti-CD20 antibody [EP459Y] (Ab78237)
CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1
详细信息
特异性
For optimal performance in IHC, the primary antibody should be incubated overnight at 4°C.
背景信息
What is this antibody validated in? Anti-CD20 antibody [EP459Y] (ab78237) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of CD20? Anti-CD20 [EP459Y] (ab78237) specifically detects a band for CD20 (UniProt: P11836) at a molecular weight of 33kDa. Trusted by the scientific community Anti-CD20 [EP459Y] (ab78237) was first used in a scientific publication in 2009 and has been cited over 70 times in peer-reviewed journals. Reviewed by scientists Anti-CD20 [EP459Y] (ab78237) has over 5 independent reviews from customers. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-CD20 antibody [EP459Y] (ab78237) has been confirmed by Western blot testing in MS4A1 Knockout Raji cell line, ab273871. Other related products We have a range of other formats of antibody clone [EP459Y] also available for your convenience: ab78237, Carrier free - ab166865, Alexa Fluor® 488 - ab198941, Alexa Fluor® 647 - ab198943, Carrier free - ab214282, ab279298, ab279299, ab279300, Carrier free - ab279310, Carrier free - ab279311, Carrier free - ab279312, ab284424, PE - ab303031, APC - ab303032, HRP - ab303033, Alkaline Phosphatase - ab308897, Alexa Fluor® 594 - ab310623, Alexa Fluor® 555 - ab312151, Alexa Fluor® 568 - ab312637, FITC - ab322915 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (116)
Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis.
嗜酸性肉芽肿性血管炎中 IGF1 的气道免疫特征和治疗意义。
Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast Cancer.
应激编程的免疫微环境促进 TNFR2+ Treg 激活,并驱动乳腺癌新辅助化疗耐药性。
Dysregulation of the endosomal sorting complex III is linked to neurodegeneration in progressive multiple sclerosis.
内体分选复合物 III 的失调与进行性多发性硬化症中的神经退行性变有关。
Diagnostic and therapeutic challenges of isolated spinal vasculitis: A case report.
孤立性脊髓血管炎的诊断和治疗挑战:病例报告。
Multi-omics analysis of BTF3L4 as a prognostic and immune biomarker in hepatocellular carcinoma.
BTF3L4作为肝细胞癌预后和免疫生物标志物的多组学分析。
Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy
FOLFOX-HAIC治疗后,肝细胞癌中三级淋巴结构的增强形成塑造了抗肿瘤微环境。
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy
干扰 AGR2/IGF1 旁分泌和相互信号传导以治疗胰腺癌
Genomic landscape and molecular subtypes of primary central nervous system lymphoma.
原发性中枢神经系统淋巴瘤的基因组图谱和分子亚型。
Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling.
原发性难治性弥漫性大B细胞淋巴瘤的低分割放射治疗和免疫化疗的II期试验:数字空间分析的初步结果和见解
- 1
- 2
- 3
- 4
- 5
- 6
- 12